Take5Care+ self-management program for newly diagnosed blood cancers
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a self-management education program to help people recently diagnosed with certain blood cancers learn skills to manage their health. It is for those on low-intensity treatments or active monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a certain blood cancer within the last 3 months.
- You are on a low-intensity oral therapy or being watched without active treatment.
- You are able to complete daily activities and give informed consent.
- Your doctor agrees that this trial is safe for you to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
This study tests an approach to help people with certain blood cancers and their main caregiver plan ahead and communicate more clearly about end-of-life care. It may help patients feel more supported and better prepared for difficult decisions.
This trial studies whether adding palliative care (comfort-focused care to reduce stress and symptoms) helps people during adoptive cell therapy for blood cancers. It may help improve quality of life while you’re receiving the therapy.
This trial tests a new treatment using specially engineered immune cells (NK cells) that target the CD5 protein found on certain T-cell blood cancers. The cells are given after a short course of chemotherapy to help them work better. It may be an option for people with aggressive T-cell cancers that have not responded to standard therapy.
This study tests a program to help caregivers of patients receiving a stem cell transplant (bone marrow transplant) for blood cancer. It aims to reduce stress and provide support during this challenging time.
This trial tests a community-based physical activity program designed for people who have had cancer or care for someone who has. The goal is to see if it can help improve health and well-being for those not currently on active treatment.
Hear when a new Hematologic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.